Page 3 - Api Holdings News Today

Why PharmEasy bought Thyrocare SUBSCRIBE Thank you for subscribing to Morning Dispatch Well soon meet in your inbox. / Morning Dispatch PharmEasy, forked out Rs 4,546 crore for a controlling stake in diagnostics firm Thyrocare last week, becoming the first startup unicorn to acquire a listed legacy company in India. We spoke to Siddharth Shah, co-founder and CEO of API Holdings, on why he decided to buy, and to Arokiaswamy Velumani, promoter of Thyrocare, on why he decided to sell. Also in th...

Exclusive content, features, opinions and comment - hand-picked by our editors, just for you. Pick 5 of your favourite companies. Get a daily email with all the news updates on them. Track the industry of your choice with a daily newsletter specific to that industry. Stay on top of your investments. Track stock prices in your portfolio. NOTE : The monthly duration product is an auto renewal based product. Once subscribed, subject to your c...

Exclusive content, features, opinions and comment - hand-picked by our editors, just for you. Pick 5 of your favourite companies. Get a daily email with all the news updates on them. Track the industry of your choice with a daily newsletter specific to that industry. Stay on top of your investments. Track stock prices in your portfolio. NOTE : The monthly duration product is an auto renewal based product. Once subscribed, subject to your c...

The total size of the transaction could be about $40 million and may value the company at about $1.8 billion, up from the current $1.5 billion valuation.

PharmEasy is said to have also begun exploratory talks to raise around Rs 3,000-Rs 3,700 crore through an IPO.

Indias startup economy has thrived on the back of an increasing number of businesses pivoting to work-from-home models and consumers increased reliance on the internet.

Share on API Holdings, the holding company of online pharmacy startup PharmEasy, has raised $350 million in a Series E round led by Prosus Ventures and TPG growth at a reported valuation of $1.5 billion, making Pharmeasy the seventh startup from India to enter the unicorn club this year. A statement from API Holdings said the new capital raised was a combination of primary and secondary funding, which also saw participation of existing investors including Temasek, CDPQ, LGT Lightrock, Eight Roa...

India: PharmEasy enters unicorn club with $350m Series E round Photographer: Krisztian Bocsi/Bloomberg April 7, 2021 API Holdings, the parent company of online pharmacy PharmEasy, has raised $350 million in a Series E funding round led by Prosus Ventures and TPG Growth. The financing, which involves a mix of primary and secondary transactions, saw the participation of existing investors including Temasek, CDPQ, LGT Lightrock, Eight Roads & Think Investments, API Holdings said in a statement. Wh...